(Q36715614)

English

Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2.

scientific article published on December 2006

Statements

Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2 (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit